Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (505)	3/30/1999 11:30:00 PM
From: BDR	Respond to of 10293

"Abbott has just guaranteed a captive buying audience." From the press release: <<Abbott Laboratories Inc. said Tuesday that it has a contract with Consorta Inc., a group purchaser representing more than half the Catholic hospitals in the United States, for intravenous solutions and related products valued at nearly $500 million.>> You better believe that if Consorta has agreed to buy $500 million only from Abbott that they are going to demand razor thin margins in return. Consorta may have just acquired a captive seller and not vice versa.